• Western blot analysis of the lysates from 293 cells using ATPBD3 antibody.
  • Western blot analysis of lysates from LOVO cells, using ATPBD3 Antibody. The lane on the right is blocked with the synthesized peptide.

Anti-CTU1 antibody (291-340 aa) (STJ91779)

SKU:
STJ91779

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Cytoplasmic tRNA 2-thiolation protein 1 (291-340 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
ELISA 1:20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: CTU1
Gene ID: 90353
Uniprot ID: CTU1_HUMAN
Immunogen Region: 291-340 aa
Specificity: ATPBD3 Polyclonal Antibody detects endogenous levels of ATPBD3 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human ATPBD3 at the amino acid range 291-340
Protein Name Cytoplasmic Trna 2-Thiolation Protein 1
Atp-Binding Domain-Containing Protein 3
Cancer-Associated Gene Protein
Cytoplasmic Trna Adenylyltransferase 1
Database Links Reactome: R-HSA-6782315
Cellular Localisation Cytoplasm
Alternative Antibody Names Anti-Cytoplasmic Trna 2-Thiolation Protein 1 antibody
Anti-Atp-Binding Domain-Containing Protein 3 antibody
Anti-Cancer-Associated Gene Protein antibody
Anti-Cytoplasmic Trna Adenylyltransferase 1 antibody
Anti-CTU1 antibody
Anti-ATPBD3 antibody
Anti-NCS6 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance